Infections in neutropenic patients I: Aetiology

Medical Oncology

Volumn 12, Issue 4, 1995, Pages 251-256

  Engervall, Per ^a   Björkholm, Magnus ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

fungal infections; neutropenia; septicemia

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; FOSCARNET; GANCICLOVIR;

BACTEREMIA; BACTERIAL INFECTION; CYTOMEGALOVIRUS INFECTION; FEVER; HERPES; HUMAN; INFECTION; MORTALITY; MYCOSIS; NEUTROPENIA; PRIORITY JOURNAL; REVIEW; SEPTIC SHOCK; VIRUS INFECTION;

BACTERIAL INFECTIONS; HUMANS; MYCOSES; NEUTROPENIA; VIRUS DISEASES;

EID: 0029550985     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/BF02990570     Document Type: Review

References (65)

1. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia
2. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever
3. A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia
4. Ceftazidime monotherapy is as effective as ceftazidime combined with gentamicin in the treatment of febrile neutropenic patients
5. Vancomycin added to empirical combination antibiotic therapy for fever in granulocy- topenic cancer patients
6. Ceftazidime compared with piperacillin and tobramycin for empiric treatment of fever in neutropenic patients with cancer
7. Bacteremia at Boston City Hospital: occurrence and mortality during 12 selected years (1935-1972), with special reference to hospital acquired cases
8. Multivariate analysis of factors associated with invasive fungal disease during remission induction therapy for acute myelogenous leukemia
9. Fever and neutropenia during intensive chemotherapy
10. Management of fever in patients with cancer and treatment induced neutropenia
11. A 10-year survey of clinically significant blood culture isolates and antibiotic susceptibilities from adult patients with hematological diseases at a major Swedish hospital
12. Incidence and clinical significance of positive blood cultures in febrile episodes of patients with haematological malignancies
13. Bacterial translocation and gram-negative bacteremia in patients with hematological malignancies
14. Origin of infection in acute nonlymphocytic leukemia. Significance of hospital acquisition of potential pathogens
15. Pseudomonas bacteremia: Retrospective analysis of 410 episodes
16. Escherichia coli bacteremia in cancer patients
17. Septicemia in patients with hematological disorders and neutropenia. A retrospective study of causative agents and their resistance profile
18. Toxic shock syndrome-associated staphylococcal and streptococcal pyrogenic toxins are potent inducers of tumor necrosis factor production
19. Coagulase-negative staphylococcal bacteremia. Mortality and hospital stay
20. Staphylococcus epidermidis: an increasing cause of infection in patients with granulocytopenia
21. Clinically significant coagulase-negative staphylococci: identification and resistance patterns
22. Bacteremia due to viridans streptococci in neutropenic patients: a review
23. Septicemia and shock syndrome due to viridans streptococci: a case-control study of predisposing factors
24. Anaerobic bacteremia in patients with acute leukemia
25. Anorectal infections in patients with malignant diseases
26. Acute abdominal pain in the granulocytopenic patient — a clinical dilemma. (Swedish)
27. Neutropenic enterocolitis
28. Clostridium difficile colitis
29. Clostridium difficile colitis in leukemia patients
30. Clostridium difficile in haematological malignancy
31. Disseminated mycobacterium malmoense infection in a patient with chronic granulocytic leukemia
32. Significance of granulomas in the bone marrow
33. Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia
34. Nosocomial fungal infections. Old problems and new challenges
35. Candida and Aspergillus infections in immunocompromised patients
36. Overview of management of fungal infections: Part 1
37. Comparative trial of ketoconazole and nystatin for the prevention of fungal infection in neutropenic patients treated within protected environment
38. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole
39. Fungal infections in neutropenic patients. Necessary with adequate prophylaxis
40. A controlled trial of fluconazole to prevent infections in patients undergoing bone marrow transplantation
41. Invasive fungal disease in pediatric acute leukemia patients with fever and neutropenia during induction chemotherapy: A multivariate analysis of risk factors
42. Pulmonary infiltrations in febrile patients with neutropenia
43. Detection of circulating Candida enolase by immunoassay in patients with cancer and invasive candidiasis
44. Severe Candidal infections in neutropenic patients
45. Hepatic candidiasis: an increasing problem in immunocompromised patients
46. Successful treatment of hepatosplenic candidiasis with a liposomal amphotericin B preparation. A case report
47. Nosocomial pneumonia in adult patients undergoing bone marrow transplantation
48. Invasive pulmonary Aspergillosis in early diagnosis and treatment
49. Invasive pulmonary Aspergillosis in adult acute leukemia: clinical clues to its diagnosis
50. Invasive pulmonary Aspergillosis in acute leukemia. The contribution of CT to early diagnosis and aggressive management
51. Pneumocystis carinii pneumonia: a cluster of eleven cases
52. Pneumocystis carinii pneumonitis
53. Herpes simplex infections in hematological malignancies
54. Antibiotic resistant fever associated with herpes simplex virus infection in neutropenic patients with haematological malignancy
55. Herpes group viruses infections in the compromised host
56. Acyclovir prophylaxis of herpes-simplex-virus infections: a randomized, double-blind, controlled trial in bone-marrow-transplant recipients
57. Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic marrow transplantation. N
58. Oral acyclovir prophylaxis for bacterial infections during induction therapy for acute leukemia in adults
59. Treatment and prevention of cytomegalovirus pneumonia after bone marrow transplantation: where do we stand?
60. Late seroconversion and high chronicity rate of hepatitis C virus infection in patients with hematological disorders
61. Frequent patient-to-patient transmission of hepatitis C virus in a Haematology ward
62. Influenza B in transplant patients
63. Influenza A in immunocompromised patients